Published in Clin J Am Soc Nephrol on December 01, 2009
Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int (2010) 2.59
Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int (2012) 1.82
Disentangling the ultrafiltration rate-mortality association: the respective roles of session length and weight gain. Clin J Am Soc Nephrol (2013) 1.67
Interdialytic weight gain in oligoanuric children and adolescents on chronic hemodialysis. Pediatr Nephrol (2014) 1.56
Reverse Remodeling and Prognosis Following Kidney Transplantation in Contemporary Patients With Cardiac Dysfunction. J Am Coll Cardiol (2015) 1.45
Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart. Nat Commun (2012) 1.25
Effect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis. Am J Kidney Dis (2012) 1.17
Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int (2012) 1.15
Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate. PLoS One (2012) 1.09
Reversed dipper blood-pressure pattern is closely related to severe renal and cardiovascular damage in patients with chronic kidney disease. PLoS One (2013) 1.01
Cardiovascular complications in children with chronic kidney disease. Nat Rev Nephrol (2011) 0.98
Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate. J Am Soc Nephrol (2014) 0.96
Noninvasive imaging for assessment of calcification in chronic kidney disease. Nat Rev Nephrol (2011) 0.91
Mineral (Mal)Adaptation to Kidney Disease-Young Investigator Award Address: American Society of Nephrology Kidney Week 2014. Clin J Am Soc Nephrol (2015) 0.91
Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD. Nephrol Dial Transplant (2014) 0.91
Randomized Controlled Trial of Individualized Dialysate Cooling for Cardiac Protection in Hemodialysis Patients. Clin J Am Soc Nephrol (2015) 0.91
Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass. BMC Nephrol (2013) 0.90
Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins. J Physiol (2014) 0.90
Diastolic dysfunction is an independent predictor of cardiovascular events in incident dialysis patients with preserved systolic function. PLoS One (2015) 0.88
Long-term effects of spironolactone in peritoneal dialysis patients. J Am Soc Nephrol (2013) 0.86
Malnutrition, renal dysfunction and left ventricular hypertrophy synergistically increase the long-term incidence of cardiovascular events. Hypertens Res (2016) 0.84
Association between sleep quality and cardiovascular damage in pre-dialysis patients with chronic kidney disease. BMC Nephrol (2014) 0.84
Cystatin C estimated renal dysfunction predicts T wave axis deviation in US adults: results from NHANES III. Eur J Epidemiol (2010) 0.83
Cardiorenal syndromes. World J Cardiol (2011) 0.83
Advanced Parameters of Cardiac Mechanics in Children with CKD: The 4C Study. Clin J Am Soc Nephrol (2015) 0.82
Cardiorenal syndromes: pathophysiology to prevention. Int J Nephrol (2010) 0.81
Implications of Klotho in vascular health and disease. World J Cardiol (2014) 0.81
Electrocardiographic left ventricular hypertrophy and outcome in hemodialysis patients. PLoS One (2012) 0.80
The association between arterial stiffness and fluid status in peritoneal dialysis patients. Perit Dial Int (2014) 0.80
Intradialytic hypotension and cardiac remodeling: a vicious cycle. Biomed Res Int (2015) 0.80
Left ventricular mass in dialysis patients, determinants and relation with outcome. Results from the COnvective TRansport STudy (CONTRAST). PLoS One (2014) 0.79
Predictive factors associated with increased progression to dialysis in early chronic kidney disease (stage 1-3) patients. Clin Exp Nephrol (2015) 0.79
Heart failure in patients with chronic kidney disease: a systematic integrative review. Biomed Res Int (2014) 0.78
Left Ventricular Global Longitudinal Strain (GLS) Is a Superior Predictor of All-Cause and Cardiovascular Mortality When Compared to Ejection Fraction in Advanced Chronic Kidney Disease. PLoS One (2015) 0.78
Extrarenal effects of FGF23. Pediatr Nephrol (2016) 0.78
Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network). J Am Heart Assoc (2017) 0.77
Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease. Curr Opin Nephrol Hypertens (2014) 0.77
Longitudinal association of body mass index and waist circumference with left ventricular mass in hypertensive predialysis chronic kidney disease patients. Nephrol Dial Transplant (2013) 0.77
Calcium as a cardiovascular toxin in CKD-MBD. Bone (2016) 0.76
Changes in echocardiographic parameters according to the rate of residual renal function decline in incident peritoneal dialysis patients. Medicine (Baltimore) (2015) 0.76
Connecting the dots on fibroblast growth factor 23 and left ventricular hypertrophy. Nephrol Dial Transplant (2016) 0.76
Three-Dimensional Imaging of a Central Venous Dialysis Catheter Related Infected Thrombus. Case Rep Nephrol (2015) 0.75
Serum Bicarbonate Is Associated with Heart Failure in the Multi-Ethnic Study of Atherosclerosis. Am J Nephrol (2016) 0.75
Hyperphosphatemia. The hidden killer in chronic kidney disease. Saudi Med J (2015) 0.75
Estimated pulmonary artery systolic pressure and self-reported physical function in patients on hemodialysis. Am J Nephrol (2015) 0.75
Decline of Renal Function and Progression of Left Ventricular Hypertrophy Are Independently Determined in Chronic Kidney Disease Stages 3-5. Pulse (Basel) (2014) 0.75
Lower serum potassium associated with increased mortality in dialysis patients: A nationwide prospective observational cohort study in Korea. PLoS One (2017) 0.75
Renal dysfunction and diastolic impairment among British ethnic minorities with hypertension: the Ethnic-Echocardiographic Heart of England Screening Study. J Hum Hypertens (2016) 0.75
Imaging of Myocardial Fibrosis in Patients with End-Stage Renal Disease: Current Limitations and Future Possibilities. Biomed Res Int (2017) 0.75
Predictive Value of Echocardiographic Abnormalities and the Impact of Diastolic Dysfunction on In-hospital Major Cardiovascular Complications after Living Donor Kidney Transplantation. Int J Med Sci (2016) 0.75
Characterisation of cardiomyopathy by cardiac and aortic magnetic resonance in patients new to hemodialysis. Eur Radiol (2015) 0.75
Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease. J Am Heart Assoc (2016) 0.75
Clinical, patient-related, and economic outcomes of home-based high-dose hemodialysis versus conventional in-center hemodialysis. Int J Nephrol Renovasc Dis (2016) 0.75
Echocardiographic changes in patients with stage 3-5 chronic kidney disease and left ventricular diastolic dysfunction. Cardiorenal Med (2014) 0.75
Serum Bicarbonate and Structural and Functional Cardiac Abnormalities in Chronic Kidney Disease - A Report from the Chronic Renal Insufficiency Cohort Study. Am J Nephrol (2016) 0.75
Prognostic Significance of Left Ventricular Mass Index and Renal Function Decline Rate in Chronic Kidney Disease G3 and G4. Sci Rep (2017) 0.75
Syndecan-4 Is an Independent Predictor of All-Cause as Well as Cardiovascular Mortality in Hemodialysis Patients. PLoS One (2016) 0.75
High Prevalence of Cardiovascular Disease in End-Stage Kidney Disease Patients Ongoing Hemodialysis in Peru: Why Should We Care About It? Int J Nephrol (2015) 0.75
Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients. J Cardiovasc Magn Reson (2017) 0.75
Association between Clinical and Doppler Echocardiographic Parameters with Sudden Death in Hemodialysis Patients. Arq Bras Cardiol (2016) 0.75
Oxidative stress and cardiac dysfunction in children with chronic renal failure on regular hemodialysis. Pediatr Nephrol (2016) 0.75
IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly. Kidney Int (2005) 2.78
Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol (2008) 2.44
Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int (2005) 2.42
Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis (2006) 2.09
Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients. Nephrol Dial Transplant (2006) 1.90
The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study. Nephrol Dial Transplant (2004) 1.62
Association of ethnicity and survival in peritoneal dialysis: a cohort study of incident patients in Brazil. Am J Kidney Dis (2013) 1.51
Sevelamer carbonate reduces inflammation and endotoxemia in an animal model of uremia. Blood Purif (2010) 1.47
Prenatal diagnosis of left ventricular aneurysm and diverticulum. Arq Bras Cardiol (2009) 1.44
[Assessment and management of cardiovascular disease in patients with chronic kidney disease]. J Bras Nefrol (2010) 1.41
Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients. Clin J Am Soc Nephrol (2011) 1.36
Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD. Perit Dial Int (2009) 1.34
Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Int (2008) 1.32
Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr (2004) 1.30
Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6? Kidney Int Suppl (2002) 1.20
Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol (2003) 1.16
Diastolic heart failure in dialysis patients: mechanisms, diagnostic approach, and treatment. Semin Dial (2012) 1.12
Family income and survival in Brazilian Peritoneal Dialysis Multicenter Study Patients (BRAZPD): time to revisit a myth? Clin J Am Soc Nephrol (2011) 1.12
Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy. J Am Soc Nephrol (2003) 1.09
Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int (2004) 1.07
Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Nephrol Dial Transplant (2004) 1.07
Insulin resistance and glucose homeostasis in peritoneal dialysis. Perit Dial Int (2009) 1.01
Development of a formula for estimation of sodium intake from spot urine in people with chronic kidney disease. Nephron Clin Pract (2014) 1.00
Update on interleukin-6 and its role in chronic renal failure. Nephrol Dial Transplant (2003) 0.99
Predictive value of malnutrition markers for mortality in peritoneal dialysis patients. J Ren Nutr (2010) 0.98
Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease. Am J Clin Nutr (2005) 0.96
Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism. J Ren Nutr (2011) 0.94
Peritoneal dialysis in Brazil: twenty-five years of experience in a single center. Perit Dial Int (2009) 0.92
Vascular damage in kidney disease: beyond hypertension. Int J Hypertens (2011) 0.92
Effect of preload reduction by hemodialysis on left atrial volume and echocardiographic Doppler parameters in patients with end-stage renal disease. Am J Cardiol (2004) 0.90
Association among oral health parameters, periodontitis, and its treatment and mortality in patients undergoing hemodialysis. J Periodontol (2013) 0.90
Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients. J Ren Nutr (2008) 0.89
Inflammation, malnutrition and atherosclerosis in end-stage renal disease: a global perspective. Blood Purif (2002) 0.88
Elevated serum 8-oxo-dG in hemodialysis patients: a marker of systemic inflammation? Antioxid Redox Signal (2006) 0.88
Peritoneal dialysis in the developing world: recommendations from a symposium at the ISPD meeting 2008. Perit Dial Int (2009) 0.88
A gut feeling on endotoxemia: causes and consequences in chronic kidney disease. Nephron Clin Pract (2010) 0.88
Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Scand J Urol Nephrol (2004) 0.87
Factors contributing to the differences in peritonitis rates between centers and regions. Perit Dial Int (2007) 0.86
Association between vitamin D receptor gene polymorphisms and susceptibility to chronic kidney disease and periodontitis. Blood Purif (2007) 0.86
Impact of residual renal function on volume status in chronic renal failure. Blood Purif (2004) 0.85
Hypovitaminosis D is associated with systemic inflammation and concentric myocardial geometric pattern in hemodialysis patients with low iPTH levels. Nephron Clin Pract (2011) 0.84
Oral health in Brazilian patients with chronic renal disease. Rev Med Chil (2008) 0.84
Echocardiography in chronic kidney disease: diagnostic and prognostic implications. Nephron Clin Pract (2010) 0.84
Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease. Kidney Int (2004) 0.84
Geography of peritoneal dialysis in Brazil: analysis of a cohort of 5,819 patients (BRAZPD). J Bras Nefrol (2010) 0.83
[Echocardiographic alterations in patients with chronic kidney failure undergoing hemodialysis]. Arq Bras Cardiol (2010) 0.83
Malnutrition and inflammation are associated with impaired pulmonary function in patients with chronic kidney disease. Nephrol Dial Transplant (2004) 0.83
Usefulness of left atrial volume for the differentiation of normal from pseudonormal diastolic function pattern in patients on hemodialysis. J Am Soc Echocardiogr (2007) 0.83
Inflammation and the peritoneal membrane: causes and impact on structure and function during peritoneal dialysis. Mediators Inflamm (2012) 0.83
The malnutrition and inflammation axis in pediatric patients with chronic kidney disease. Pediatr Nephrol (2007) 0.82
Burden of disease: prevalence and incidence of ESRD in Latin America. Clin Nephrol (2015) 0.82
[Prevalence and prognostic impact of diastolic dysfunction in patients with chronic kidney disease on hemodialysis]. Arq Bras Cardiol (2010) 0.81
Peritoneal dialysis in the developing world: lessons from the Sudan. Perit Dial Int (2007) 0.81
IL-8 but not other biomarkers of endothelial damage is associated with disease activity in patients with ankylosing spondylitis without treatment with anti-TNF agents. Rheumatol Int (2013) 0.80
Plasma cysteine/cystine reduction potential correlates with plasma creatinine levels in chronic kidney disease. Blood Purif (2012) 0.80
Leptin, ghrelin, and proinflammatory cytokines: compounds with nutritional impact in chronic kidney disease? Adv Ren Replace Ther (2003) 0.80
Understanding the role of genetic polymorphisms in chronic kidney disease. Pediatr Nephrol (2008) 0.80
Interleukin-1 gene cluster polymorphisms are associated with nutritional status and inflammation in patients with end-stage renal disease. Blood Purif (2005) 0.80
Similar outcomes of catheters implanted by nephrologists and surgeons: analysis of the Brazilian peritoneal dialysis multicentric study. Semin Dial (2012) 0.80
Increased calcification and protein nitration in arteries of chronic kidney disease patients. Blood Purif (2011) 0.80
Is UCP2 gene polymorphism associated with decreased resting energy expenditure in nondialyzed chronic kidney disease patients? J Ren Nutr (2008) 0.80
The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients. Nephrol Dial Transplant (2004) 0.80
Gene polymorphism association studies in dialysis: the nutrition-inflammation axis. Semin Dial (2005) 0.79
Analysis of IL1 gene polymorphisms and transcript levels in periodontal and chronic kidney disease. Cytokine (2012) 0.79
Insulin resistance is associated with circulating fibrinogen levels in nondiabetic patients receiving peritoneal dialysis. J Ren Nutr (2007) 0.78
Comparative analysis of lipid and glucose metabolism biomarkers in non-diabetic hemodialysis and peritoneal dialysis patients. J Bras Nefrol (2011) 0.78
Analysis of the association of an MMP1 promoter polymorphism and transcript levels with chronic periodontitis and end-stage renal disease in a Brazilian population. Arch Oral Biol (2012) 0.78
Association between left atrium enlargement and intradialytic hypotension: role of diastolic dysfunction in the hemodynamic complications during hemodialysis. Echocardiography (2009) 0.78
Association between biomarkers of carbonyl stress with increased systemic inflammatory response in different stages of chronic kidney disease and after renal transplantation. Nephron Clin Pract (2010) 0.78
Metabolic impact of peritoneal dialysis. Contrib Nephrol (2009) 0.78
Association between inflammatory markers and left atrial enlargement in patients on hemodialysis. Arq Bras Cardiol (2013) 0.78
Longitudinal changes in health-related quality of life scores in Brazilian incident peritoneal dialysis patients (BRAZPD): socio-economic status not a barrier. Perit Dial Int (2013) 0.78
Inflammation in peritoneal dialysis: a Latin-American perspective. Perit Dial Int (2007) 0.78
Periodontal diseases and systemic inflammation. Semin Dial (2012) 0.78
Novel predictors of peritonitis-related outcomes in the BRAZPD cohort. Perit Dial Int (2014) 0.77
Impact of baseline health-related quality of life scores on survival of incident patients on peritoneal dialysis: a cohort study. Nephron (2015) 0.77
Comparative analysis of two methodologies for the identification of urinary red blood cell casts. J Bras Nefrol (2011) 0.77
The recommendations from the International Society for Peritoneal Dialysis for Peritonitis Treatment: a single-center historical comparison. Adv Perit Dial (2004) 0.77
Increase in BMI over time is associated with fluid overload and signs of wasting in incident peritoneal dialysis patients. J Ren Nutr (2012) 0.76
Associations between the CYBA 242C/T and the MPO -463G/A polymorphisms, oxidative stress and cardiovascular disease in chronic kidney disease patients. Blood Purif (2007) 0.76
Brazilian Peritoneal Dialysis Multicenter Study (BRAZPD): from conception to execution of a national peritoneal dialysis reality check. Contrib Nephrol (2012) 0.76
Interaction of anemia and decrease in renal function on survival of patients with heart failure. Int J Cardiol (2011) 0.76
Back to basics: pitting edema and the optimization of hypertension treatment in incident peritoneal dialysis patients (BRAZPD). PLoS One (2012) 0.76
Saliva urea nitrogen dipstick - a novel bedside diagnostic tool for acute kidney injury. Clin Nephrol (2014) 0.75
Saliva Urea Nitrogen Continuously Reflects Blood Urea Nitrogen after Acute Kidney Injury Diagnosis and Management: Longitudinal Observational Data from a Collaborative, International, Prospective, Multicenter Study. Blood Purif (2016) 0.75
Correction: Automated Peritoneal Dialysis Is Associated with Better Survival Rates Compared to Continuous Ambulatory Peritoneal Dialysis: A Propensity Score Matching Analysis. PLoS One (2015) 0.75
The impact of living donor kidney transplantation on markers of cardiovascular risk in chronic kidney disease patients. Blood Purif (2007) 0.75
Continuing medical education program in echocardiography. Echocardiography (2009) 0.75
Use of intravascular ultrasonography for the characterization of coronary artery disease in patients with chronic kidney disease. J Bras Nefrol (2011) 0.75
Impact of Pre-Dialysis Care on Clinical Outcomes in Peritoneal Dialysis Patients. Am J Nephrol (2016) 0.75
Low-calcium peritoneal dialysis solution is effective in bringing PTH levels to the range recommended by current guidelines in patients with PTH levels < 150 pg/dL. J Bras Nefrol (2010) 0.75
Impact of Renin-Angiotensin Aldosterone System Inhibition on Serum Potassium Levels among Peritoneal Dialysis Patients. Am J Nephrol (2017) 0.75
Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference. Eur J Emerg Med (2020) 0.75
Uremic Toxicity-Induced Eryptosis and Monocyte Modulation: The Erythrophagocytosis as a Novel Pathway to Renal Anemia. Blood Purif (2016) 0.75
Role of Organic Anion Transporters in the Uptake of Protein-Bound Uremic Toxins by Human Endothelial Cells and Monocyte Chemoattractant Protein-1 Expression. J Vasc Res (2017) 0.75
Controlling inflammation in peritoneal dialysis: the role of pd-related factors as potential intervention targets. Perit Dial Int (2007) 0.75